{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:08:23Z","timestamp":1792213703400,"version":"4.4.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bioorg.2022.106254","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:30:01Z","timestamp":1669595401000},"page":"106254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands"],"prefix":"10.1016","volume":"131","author":[{"given":"Deepika","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjani Kumar","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.106254_b0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"9","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106254_b0010","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0893-133X(99)00031-7","article-title":"The discovery of serotonin and its role in neuroscience","volume":"21","author":"Whitaker-Azmitia","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bioorg.2022.106254_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00391792","article-title":"Ricerche sul secreto delle cellule enterocromaffini - Nota VII Osservazioni critiche su alcuni problemi inerenti alla istochimica delle enterocromaffini","volume":"27","author":"Vialli","year":"1937","journal-title":"Z. Zellforsch. Mikroskopische Anat."},{"key":"10.1016\/j.bioorg.2022.106254_b0020","first-page":"76","article-title":"Selective serotonin inhibitors and their perspectives in ophthalmology","volume":"12","author":"Markova","year":"2015","journal-title":"Ophthalmol. Russ."},{"key":"10.1016\/j.bioorg.2022.106254_b0025","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/169800b0","article-title":"Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine","volume":"169","author":"Erspamer","year":"1952","journal-title":"Nature."},{"key":"10.1016\/j.bioorg.2022.106254_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.108.2804.329","article-title":"Crystalline serotonin","volume":"108","author":"Rapport","year":"1948","journal-title":"Science."},{"key":"10.1016\/j.bioorg.2022.106254_b0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0021-9258(19)51208-X","article-title":"serum vasoconstrictor (serotonin)","volume":"180","author":"Rapport","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0021-9258(18)57136-2","article-title":"Page, serum vasoconstrictor (serotonin): iii. chemical inactivation","volume":"176","author":"Rapport","year":"1948","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1113\/jphysiol.1953.sp004850","article-title":"Distribution of 5-hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tract","volume":"119","author":"Feldberg","year":"1953","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2022.106254_b0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.55782\/ane-1996-1167","article-title":"Evolutionary ancient roles of serotonin: long-lasting regulation of activity and development","volume":"56","author":"Turlejski","year":"1996","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"10.1016\/j.bioorg.2022.106254_b0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.275.5299.530","article-title":"Measuring serotonin distribution in live cells with three-photon excitation","volume":"275","author":"Maiti","year":"1997","journal-title":"Science."},{"key":"10.1016\/j.bioorg.2022.106254_b0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1139\/jpn.0738","article-title":"How to increase serotonin in the human brain without drugs","volume":"32","author":"Young","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bioorg.2022.106254_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/ajplegacy.1953.175.1.157","article-title":"Serotonin content of some mammalian tissues and urine and a method for its determination","volume":"175","author":"Twarog","year":"1953","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bioorg.2022.106254_b0070","doi-asserted-by":"crossref","unstructured":"B.B. Brodie, A. Pletscher, P.A. Shore, Evidence that serotonin has a role in brain function, Science 122 (1955) 968\u2013968. <https:\/\/doi.org\/10.1126\/science.122.3177.968.A>.","DOI":"10.1126\/science.122.3177.968.a"},{"key":"10.1016\/j.bioorg.2022.106254_b0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)26041-4","article-title":"The enzymic oxidation of tryptophan to 3-hydroxytryptophan in the biosynthesis of serotonin","volume":"132","author":"Cooper","year":"1961","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2022.106254_b0080","doi-asserted-by":"crossref","unstructured":"Substituted 3-(4-(1, 3, 5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors, Bioorg. Med. Chem. Lett.19(2009) 5229-5232. 10.1016\/j.bmcl.2009.07.005.","DOI":"10.1016\/j.bmcl.2009.07.005"},{"key":"10.1016\/j.bioorg.2022.106254_b0085","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function","volume":"100","author":"C\u00f4t\u00e9","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2022.106254_b0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1016\/j.bioorg.2022.106254_b0095","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/jm800338j","article-title":"Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders","volume":"51","author":"Shi","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(72)90222-3","article-title":"Relationship between brain monoamine levels and sidman avoidance behavior in rats treated with tyrosine and tryptophan hydroxylase inhibitors","volume":"45","author":"Tanaka","year":"1972","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bioorg.2022.106254_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.107.132670","article-title":"Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract","volume":"325","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2022.106254_b0110","series-title":"Kaufman\u2019s Clinical Neurology for Psychiatrists","author":"Kaufman","year":"2022"},{"key":"10.1016\/j.bioorg.2022.106254_b0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2018.06.016","article-title":"Serotonin and human cancer: a critical view","volume":"161","author":"Sarrouilhe","year":"2019","journal-title":"Biochimie."},{"key":"10.1016\/j.bioorg.2022.106254_b0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1155\/2008\/472159","article-title":"Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake","volume":"22","author":"Joy","year":"2008","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2022.106254_b0125","doi-asserted-by":"crossref","first-page":"43694","DOI":"10.1074\/jbc.M112.342212","article-title":"Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket","volume":"287","author":"S\u00f8rensen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00002512-199813050-00002","article-title":"Monoamine oxidase inhibitors. A perspective on their use in the elderly","volume":"13","author":"Volz","year":"1998","journal-title":"Drugs Aging."},{"key":"10.1016\/j.bioorg.2022.106254_b0135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2174\/156802606778249810","article-title":"Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century \u2013 a medicinal chemistry survey","volume":"6","author":"Moltzen","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0140","first-page":"863","article-title":"Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies","volume":"33","author":"Tong","year":"2013","journal-title":"J. Sagepub. Com."},{"key":"10.1016\/j.bioorg.2022.106254_b0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fnbeh.2014.00306","article-title":"Cellular mechanisms of the 5-HT7 receptor-mediated signaling","volume":"8","author":"Guseva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bioorg.2022.106254_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00210-008-0276-9","article-title":"Serotonin pharmacology in the gastrointestinal tract: a review","volume":"377","author":"Beattie","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0155","unstructured":"D.E. Felsing, drug discovery targeting serotonin g protein-coupled receptors in the treatment of neuropsychiatric disorders, (2016) (Doctoral dissertation, University of Florida)."},{"key":"10.1016\/j.bioorg.2022.106254_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00162","article-title":"The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory","volume":"6","author":"Stiedl","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neubiorev.2006.01.001","article-title":"Serotonin and the neurobiology of the ejaculatory threshold","volume":"30","author":"de Jong","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bioorg.2022.106254_b0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2008.06.026","article-title":"Serotonergic mechanisms in addiction-related memories","volume":"195","author":"Nic Dhonnchadha","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2022.106254_b0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"P5-HT1A receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.bioorg.2022.106254_b0180","article-title":"Synthesis and evaluation of technetium-99m labelled 1-(2-methoxyphenyl)piperazine derivative for single photon emission computed tomography imaging for targeting 5-HT1A","volume":"111(104972)","author":"Kumari","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0185","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ddr.21930","article-title":"Benzoxazolone-arylpiperazinyl scaffold-based PET ligand for 5-HT 7: synthesis and biological evaluation","volume":"83","author":"Kumari","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2022.106254_b0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2022.106254_b0195","doi-asserted-by":"crossref","unstructured":"A. K. Tiwari, J. Yui, Pooja, S. Aggarwal, T. Yamasaki, L. Xie, N. Chadha, Y. Zhang, M. Fujinaga, Y. Shimoda, K. Kumata, A. K. Mishra, M. Ogawaac and M.-R. Zhang, Design, synthesis and biological evaluation of small molecule-based PET radioligands for the 5-hydroxytryptamine 7 receptor, RSC Adv. 5 (2015) 19752\u201319759. <https:\/\/doi.org\/10.1039\/C4RA15833D>.","DOI":"10.1039\/C4RA15833D"},{"issue":"1990","key":"10.1016\/j.bioorg.2022.106254_b0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199000157-00002","article-title":"Identification and classification of 5-HT1 receptor subtypes","volume":"15","author":"G\u00f6thert","year":"1990","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0922-4106(90)90190-9","article-title":"The concept of selectivity in 5-HT receptor research","volume":"188","author":"Van Wijngaarden","year":"1990","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-0348-8730-4_3","article-title":"The 5-HT(1A) receptor and its ligands: Structure and function","volume":"52","author":"Olivier","year":"1999","journal-title":"Prog. Drug Res."},{"issue":"2001","key":"10.1016\/j.bioorg.2022.106254_b0215","first-page":"999","article-title":"Serotonin receptor and transporter ligands-current status","volume":"8","author":"Oh","year":"2001","journal-title":"Ingentaconnect. Com."},{"key":"10.1016\/j.bioorg.2022.106254_b0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/0929867023371030","article-title":"Arylpiperazine derivatives acting at 5-HT1A receptors","volume":"9","author":"Lopez-Rodriguez","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0225","first-page":"77","article-title":"A synthetic overview of new molecules with 5-HT1A binding affinities, mini-reviews","volume":"3","author":"Pessoa-Mahana","year":"2005","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0230","doi-asserted-by":"crossref","unstructured":"J. De Vry, R. Schohe-Loop, H.G. Heine, J.M. Greuel, F. Mauler, B. Schmidt, H. Sommermeyer, T. Glaser, Characterization of the aminomethylchroman derivative BAY\u00d7 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist, aspet. 284 (1998) 1082\u20131094.","DOI":"10.1016\/S0022-3565(24)37340-9"},{"key":"10.1016\/j.bioorg.2022.106254_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02245588","article-title":"5-HT1A receptor agonists: recent developments and controversial issues","volume":"121","author":"De Vry","year":"1995","journal-title":"Psychopharmacol. (Berl)."},{"issue":"2000","key":"10.1016\/j.bioorg.2022.106254_b0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W","article-title":"5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response","volume":"15","author":"Cryan","year":"2000","journal-title":"Hum Psychopharmacol."},{"issue":"1998","key":"10.1016\/j.bioorg.2022.106254_b0245","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0091-3057(97)00525-X","article-title":"Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression?","volume":"59","author":"Gonzalez","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bioorg.2022.106254_b0250","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0149-7634(98)00056-6","article-title":"Effects of centrally administered anxiolytic compounds in animal models of anxiety","volume":"23","author":"Menard","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2001","key":"10.1016\/j.bioorg.2022.106254_b0255","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J. Psychiat. Neurosci."},{"key":"10.1016\/j.bioorg.2022.106254_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.22058","article-title":"The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse","volume":"516","author":"Sun","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bioorg.2022.106254_b0265","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.bioorg.2022.106254_b0270","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bioorg.2022.106254_b0275","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2174\/1389450117666151209123049","article-title":"Drug targets for obesity and depression: from serotonin to leptin","volume":"17","author":"Jabeen Haleem","year":"2016","journal-title":"Curr. Drug Targets."},{"key":"10.1016\/j.bioorg.2022.106254_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007043482570","article-title":"5-HT1 receptors","volume":"3","author":"Lanfumey","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.bioorg.2022.106254_b0285","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/jm400533t","article-title":"5-HT1A receptor: An old target as a new attractive tool in drug discovery from central nervous system to cancer","volume":"57","author":"Fiorino","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2003.08.007","article-title":"8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production","volume":"46","author":"Sprouse","year":"2004","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bioorg.2022.106254_b0295","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02244440","article-title":"Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder","volume":"105","author":"Enkelmann","year":"1991","journal-title":"Psychopharmacol. (Berl)."},{"key":"10.1016\/j.bioorg.2022.106254_b0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0163-7258(94)00005-N","article-title":"Serotonin receptors: subtypes, functional responses and therapeutic relevance","volume":"66","author":"Saxena","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2022.106254_b0305","first-page":"582","article-title":"Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders","volume":"20","author":"Naumenko","year":"2014","journal-title":"Wiley Online Libr."},{"key":"10.1016\/j.bioorg.2022.106254_b0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bioorg.2022.106254_b0315","doi-asserted-by":"crossref","unstructured":"Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking, J. Cell Sci. 15 (2012) 2486\u20132499. doi: 10.1242\/jcs.101337.","DOI":"10.1242\/jcs.101337"},{"key":"10.1016\/j.bioorg.2022.106254_b0320","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0028-3908(94)90059-0","article-title":"Molecular biology of 5-HT receptors","volume":"33","author":"Boess","year":"1994","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bioorg.2022.106254_b0325","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1021\/jm00078a012","article-title":"Derivatives of 2-(dipropylamino)tetralin: effect of the c8-substituent on the interaction with 5-HT1A receptors","volume":"36","author":"Liu","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0330","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/jm00168a002","article-title":"(S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist","volume":"33","author":"Hillver","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0335","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0091-3057(91)90124-K","article-title":"Structure-activity relationships at 5-HT1A receptors: binding profiles and intrinsic activity","volume":"40","author":"Nelson","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bioorg.2022.106254_b0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-7208(97)80003-7","article-title":"5-HT1A receptor ligands","volume":"27","author":"van Wijngaarden","year":"1997","journal-title":"Pharmacochem. Libr."},{"key":"10.1016\/j.bioorg.2022.106254_b0345","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/jm00067a002","article-title":"(S)- and (R)-8-(Di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1-carbaldehyde: a new class of orally active 5-HT1A-receptor agonists","volume":"36","author":"Stjernl\u00f6f","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109313","article-title":"DNA binding and antiradical potential of ethyl pyruvate: Key to the DNA radioprotection","volume":"332","author":"Sharma","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2022.106254_b0355","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/jm00106a004","article-title":"A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin","volume":"34","author":"Mellin","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0006-8993(84)90664-4","article-title":"Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain","volume":"291","author":"Marcinkiewicz","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2022.106254_b0365","first-page":"1175","article-title":"Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors","volume":"42","author":"Harhammer","year":"1992","journal-title":"Arzneimittelforschung."},{"issue":"3","key":"10.1016\/j.bioorg.2022.106254_b0370","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/mol.52.3.515","article-title":"Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor","volume":"52","author":"Boess","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0375","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0091-3057(87)90184-5","article-title":"The effects of 8-hydroxy-2-(di-n-propylamino) tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory","volume":"27","author":"Winter","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.bioorg.2022.106254_b0380","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0223-5234(99)80065-8","article-title":"Synthesis and in vitro structure-activity relationship of 13-tert-butyl-ergoline derivatives as 5-HT1A receptor ligands","volume":"32","author":"Mantegani","year":"1997","journal-title":"Euro. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0385","doi-asserted-by":"crossref","unstructured":"M.M. Foreman, R.W. Fuller, J.D. Leander, M.J. Benvenga, D.T. Wong, D.L. Nelson, D.O. Calligaro, S.P. Swanson, J.B. Lucot, M.E. Flaugh, Preclinical studies on LY228729: a potent and selective serotonin1A agonist, J. Pharmacol. Exp. Ther. 267 (1993).","DOI":"10.1016\/S0022-3565(25)39565-0"},{"key":"10.1016\/j.bioorg.2022.106254_b0390","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/jm00397a007","article-title":"(R)-(-)-10-methyl-11-hydroxyaporphine: a highly selective serotonergic agonist","volume":"31","author":"Cannon","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0395","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm00011a002","article-title":"A-ring ortho-disubstituted aporphine derivatives as potential agonists or antagonists at serotonergic 5-HT1A receptors","volume":"38","author":"Cannon","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0400","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ardp.201300011","article-title":"New arylpiperazines with flexible versus partly constrained linker as serotonin 5-HT(1A)\/5-HT(7) receptor ligands","volume":"346","author":"Kowalski","year":"2013","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2022.106254_b0405","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/0929867023371030","article-title":"Arylpiperazine derivatives acting at 5-HT(1A) receptors","volume":"9","author":"Lopez-Rodriguez","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0410","first-page":"369","article-title":"Substitution mode of the amide fragment in some new n-{w-[4-(2-methoxyphenyl) piperazin\u20131-yl] alkyl} pyrid-2 (1h)-ones and their 5-HT1A\/5-HT2A activity","volume":"53","author":"Paluchowska","year":"2001","journal-title":"Pol. J. Pharmacol"},{"key":"10.1016\/j.bioorg.2022.106254_b0415","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/jm00021a020","article-title":"A series of N4-imidoethyl derivatives of 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A receptor ligands: synthesis and structure-affinity relationships","volume":"38","author":"van Steen","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0420","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1016\/S0968-0896(02)00349-8","article-title":"Synthesis and pharmacological evaluation of new Arylpiperazines. 3-{4-[4-(3-chlorophenyl)-1-piperazinyl] butyl}-quinazolidin-4-one\u2014a dual serotonin 5-HT1A\/5-HT2A receptor ligand with an anxiolytic-like activity","volume":"12","author":"Bojarski","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0425","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0014-827X(00)00069-0","article-title":"Synthesis, 5-HT1A and 5-HT2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2, 6-and pyrrolidine-2, 5-diones","volume":"55","author":"Paw\u0142owski","year":"2000","journal-title":"Farmaco"},{"key":"10.1016\/j.bioorg.2022.106254_b0430","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/jm001059j","article-title":"New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants","volume":"44","author":"Mart\u00ednez-Esparza","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0968-0896(00)00004-3","article-title":"Synthesis of new 1, 2, 3-benzotriazin-4-one-arylpiperazine derivatives as 5-HT1A serotonin receptor ligands","volume":"8","author":"Caliendo","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0440","first-page":"501","article-title":"2-H-and 2-acyl-9-[omega-[4-(2-methoxyphenyl) piperazinyl]-alkyl]-1, 2, 3, 4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors","volume":"53","author":"Boksa","year":"2001","journal-title":"Pol. J. Pharmacol"},{"key":"10.1016\/j.bioorg.2022.106254_b0445","first-page":"395","article-title":"Short communication arylpiperazine derivatives of 3-propyl-b-tetralonohydantoin as new 5-ht 1a and 5-ht 2a receptor ligands","volume":"53","author":"Byrtus","year":"2001","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-827X(02)01205-3","article-title":"Interaction of 1, 2, 4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors","volume":"57","author":"Chilmonczyk","year":"2002","journal-title":"Farmaco."},{"key":"10.1016\/j.bioorg.2022.106254_b0455","unstructured":"M.H. Paluchowska, M.J. Mokrosz, S. Charakchieva-Minol, B. Duszy\u00f1ska, A. Kozio3, A. Wesolowska, K. Stachowicz, E. Chojnacka-W\u00f3jcik, Novel 4-alkyl-1-arylpiperazines and 1, 2, 3, 4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A\/5-HT2A\/D2 receptor activity, Pol. J. Pharmacol. 55 (2003) 543\u2013552."},{"key":"10.1016\/j.bioorg.2022.106254_b0460","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/S0960-894X(03)00706-6","article-title":"Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A\/5-HT3 ligands","volume":"13","author":"Rodr\u0131guez","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0465","first-page":"139","article-title":"Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part III","volume":"61","author":"Herold","year":"2004","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.bioorg.2022.106254_b0470","doi-asserted-by":"crossref","unstructured":"S. Jurczyk, M. Ko\u0142aczkowski, E. Maryniak, P. Zajdel, M. Pawlowski, E. Tatarczynska, A. K\u0142odzinska, E. Chojnacka-Wojcik, A.J. Bojarski, S. Charakchieva-Minol, B. Duszynska, G. Nowak, D. Maciag, New arylpiperazine 5-HT1A receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation, J. Med. Chem. 47 (2004) 2659\u20132666. <https:\/\/doi.org\/10.1021\/JM030946U>.","DOI":"10.1021\/jm030946u"},{"key":"10.1016\/j.bioorg.2022.106254_b0475","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/90300170","article-title":"New imide 5-HT1A receptor ligands \u2013 modification of terminal fragment geometry","volume":"9","author":"Bojarski","year":"2004","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2022.106254_b0480","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.bmcl.2005.04.077","article-title":"Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs","volume":"15","author":"Kling","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0485","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jhet.5570360203","article-title":"2-Aminothiophenes by the gewald reaction","volume":"36","author":"Sabnis","year":"1999","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0490","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1021\/ja9608306","article-title":"An improved catalyst system for aromatic carbon-nitrogen bond formation: the possible involvement of bis(phosphine) palladium complexes as key intermediates","volume":"118","author":"Wolfe","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2022.106254_b0495","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1021\/jm050246k","article-title":"New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation","volume":"48","author":"Fiorino","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0500","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.bmcl.2005.06.042","article-title":"8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands","volume":"15","author":"Heightman","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0505","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bjp.0704133","article-title":"SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist in native tissue","volume":"133","author":"Watson","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"2005","key":"10.1016\/j.bioorg.2022.106254_b0510","first-page":"336","article-title":"Synthesis, anticonvulsant properties and 5-HT 1A \/5-HT 2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4] nonane and [4.5]decane-1,3-dione derivatives","volume":"57","author":"Obniska","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2022.106254_b0515","doi-asserted-by":"crossref","unstructured":"A.J. Bojarski, M.H. Paluchowska, B. Duszy\u0144ska, R. Bugno A. K\u0142odzi\u0144ska, E. Tatarczy\u0144ska, E.W. Chojnacka, Structure\u2013intrinsic activity relationship studies in the group of 1-imido\/amido substituted 4-(4-arylpiperazin-1-yl) cyclohexane derivatives; new, potent 5-HT1A receptor, Bioorg. Med. Chem. 14 (2006) 1391\u20131402. doi: 10.1016\/j.bmc.2005.09.060.","DOI":"10.1016\/j.bmc.2005.09.060"},{"key":"10.1016\/j.bioorg.2022.106254_b0520","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1021\/jm100294b","article-title":"Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors","volume":"53","author":"Butini","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0525","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.ejmech.2011.04.060","article-title":"Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A\/2A) and 5-HT(7) receptor ligands","volume":"46","author":"Lewgowd","year":"2011","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0530","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1016\/j.ejmech.2011.06.023","article-title":"Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl) piperazin-1-yl] ethyl}-N-(pyridin-2-yl) cyclohexanecarboxamide (WAY-100635) for the 5-HT1A receptor","volume":"12","author":"Hussainy","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2022.106254_b0535","doi-asserted-by":"crossref","first-page":"e84510","DOI":"10.1371\/journal.pone.0084510","article-title":"A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds \u2013 an application for 5-HT1A receptor ligands","volume":"8","author":"Warszycki","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2022.106254_b0540","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1021\/jm400766k","article-title":"New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo","volume":"56","author":"Valhondo","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0545","doi-asserted-by":"crossref","unstructured":"M.Z. Wr\u00f3bel, A. Chodkowski, F. Herold, A. Gom\u00f3\u0142ka, J. Kleps, A.P. Mazurek, F. Pluci\u0144ski, A. Mazurek, G. Nowak, A. Siwek, K. Stachowicz, A. S\u0142awi\u0144ska, M. Wolak, B. Szewczyk, G. Sata\u0142a, A.J. Bojarski, J.Tur\u0142o Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1. Eur. J. Med. Chem. 63 (2013) 484\u2013500. doi:10.1016\/j.ejmech.2013.02.033.","DOI":"10.1016\/j.ejmech.2013.02.033"},{"issue":"2013","key":"10.1016\/j.bioorg.2022.106254_b0550","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmech.2013.01.044","article-title":"Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds","volume":"63","author":"Cappelli","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0555","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ardp.201200378","article-title":"Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT1A receptor and serotonin transporter affinity","volume":"346","author":"Czopek","year":"2013","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2022.106254_b0560","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1016\/j.bmcl.2014.07.048","article-title":"Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands","volume":"24","author":"Kumar","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0565","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ardp.201400174","article-title":"Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands","volume":"347","author":"Fiorino","year":"2014","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2022.106254_b0570","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1021\/jm049702f","article-title":"Structure-affinity relationship study on n-(1,2,3,4-tetrahydronaphthalen-1- yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine 7 receptor agents","volume":"47","author":"Leopoldo","year":"2004","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.106254_b0575","doi-asserted-by":"crossref","first-page":"e1600271","DOI":"10.1002\/ardp.201600271","article-title":"Synthesis and docking of novel 3-indolylpropyl derivatives as new polypharmacological agents displaying affinity for 5-HT1AR\/SERT","volume":"350","author":"Pessoa-Mahana","year":"2017","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2022.106254_b0580","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bmc.2017.12.016","article-title":"5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives","volume":"26","author":"Ostrowska","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0585","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X15666170911121027","article-title":"Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system","volume":"16","author":"Cortes-Altamirano","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2022.106254_b0590","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/revneuro-2013-0066","article-title":"Serotonergic 5-HT7 receptors and cognition","volume":"25","author":"Gasbarri","year":"2014","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2022.106254_b0595","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.bmcl.2013.09.025","article-title":"Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties","volume":"23","author":"Lacivita","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0600","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bmcl.2005.11.067","article-title":"Aminoalkyl phenyl sulfones - a novel series of 5-HT7 receptor ligands","volume":"16","author":"Raubo","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bmc.2015.11.041","article-title":"N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile","volume":"24","author":"Canale","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0610","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/acs.jmedchem.7b00839","article-title":"Novel 3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole-based multifunctional ligands with antipsychotic-like, mood-modulating, and procognitive activity","volume":"60","author":"Bucki","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0422-5","article-title":"Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands","volume":"12","author":"Marciniec","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2022.106254_b0620","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/np500893h","article-title":"Semisynthetic studies on and biological evaluation of N-methyllaurotetanine analogues as ligands for 5-HT receptors","volume":"78","author":"Madapa","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2022.106254_b0625","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1016\/j.bmcl.2004.09.029","article-title":"The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands","volume":"14","author":"Bojarski","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106254_b0630","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jm070279v","article-title":"(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists","volume":"51","author":"Volk","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0635","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00221-013-3498-0","article-title":"Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters","volume":"230","author":"Lacivita","year":"2013","journal-title":"Exp. Brain Res."},{"issue":"85","key":"10.1016\/j.bioorg.2022.106254_b0640","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ejmech.2014.08.023","article-title":"Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands","volume":"6","author":"Salerno","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0645","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2014.01.065","article-title":"SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives","volume":"78","author":"Handzlik","year":"2014","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0650","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2014.01.055","article-title":"New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies","volume":"75","author":"Sagnes","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0655","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ardp.201500015","article-title":"New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A\/5-HT2A\/5-HT7 and dopamine D2 receptors","volume":"348","author":"Ch\u0142o\u0144-Rzepa","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2022.106254_b0660","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ardp.201400392","article-title":"Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione","volume":"348","author":"Zmudzki","year":"2015","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2022.106254_b0665","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.bmc.2007.11.049","article-title":"Novel quinazolinone derivatives as 5-HT7 receptor ligands","volume":"16","author":"Na","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2022.106254_b0670","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1021\/jm030841r","article-title":"Optimization of the pharmacophore model for 5-HT 7 R antagonism. design and synthesis of new naphtholactam and naphthosultam derivatives","volume":"46","author":"L\u00f3pez-Rodr\u00edguez","year":"2003","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2022.106254_b0675","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1021\/jm049743b","article-title":"Novel 5-HT 7 receptor inverse agonists. synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides","volume":"47","author":"Vermeulen","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0680","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1021\/jm060300c","article-title":"Receptor-based pharmacophores for serotonin 5-HT7R antagonists implications to selectivity","volume":"49","author":"Ko\u0142aczkowski","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0685","unstructured":"Molecular Operating Environment (MOE). Chemical Computing Group ULC; 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7: 2017."},{"issue":"9","key":"10.1016\/j.bioorg.2022.106254_b0690","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s11064-022-03633-w","article-title":"Current status of our understanding for brain integrated functions and its energetics","volume":"47","author":"Tiwari","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2022.106254_b0695","doi-asserted-by":"crossref","unstructured":"P. Singh, A. Adhikari, D. Singh, C. Gond, A.K. Tiwari, The 18-kDa translocator protein PET tracers as a diagnostic marker for neuroinflammation: development and current standing, ACS Omega 7(17) (2022) 14412\u201314429. <https:\/\/doi.org\/10.1021\/acsomega.2c00588>.","DOI":"10.1021\/acsomega.2c00588"},{"key":"10.1016\/j.bioorg.2022.106254_b0700","doi-asserted-by":"crossref","unstructured":"V. Srivastava, A.M. Srivastava, A.K. Tiwari, R. Srivastava, R. Sharma, H. Sharma, V.K. Singh, Disubstituted 4(3H) quinazolones: a novel class of antitumor agents, Chem. Biol. Drug Des. 74 (3) (2009) 297\u2013301. <https:\/\/doi.org\/10.1111\/j.1747-0285.2009.00850.x>.","DOI":"10.1111\/j.1747-0285.2009.00850.x"},{"issue":"19","key":"10.1016\/j.bioorg.2022.106254_b0705","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.1039\/D0NJ00509F","article-title":"Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [11C]N\u2032-MPB for visualization of 18 kDa TSPO in brain","volume":"44","author":"Tiwari","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2022.106254_b0710","doi-asserted-by":"crossref","unstructured":"D. Sinha, G. Shukla, A.K Tiwari, S. Chaturvedi, K. Chuttani, H. Chandra, A.K. Mishra, 99mTc-DTPA-Amino acids conjugate as specific spect pharmaceuticals for tumor imaging, Chem. Biol. Drug Des. 74 (2) (2009) 159\u2013164. <https:\/\/doi.org\/10.1111\/j.1747-0285.2009.00839.x>.","DOI":"10.1111\/j.1747-0285.2009.00839.x"},{"key":"10.1016\/j.bioorg.2022.106254_b0715","doi-asserted-by":"crossref","unstructured":"J.Tanwar, A. Datta, A.K. Tiwari, M. Thirumal, K. Chuttani, A.K. Mishra, Preclinical evaluation of DO3P-AME-DO3P: a polyazamacrocyclic methylene phosphonate for diagnosis and therapy of skeletal metastases, Bioconjug. Chem. 22 (2) (2011) 244\u2013255. <https:\/\/doi.org\/10.1021\/\/bc100382c>.","DOI":"10.1021\/bc100382c"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:42:33Z","timestamp":1758616953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822006605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":143,"alternative-id":["S0045206822006605"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106254","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106254"}}